Recombinant Monoclonal Human anti-Coronavirus SARS-CoV-2 Spike Glycoprotein Antibody (ECD/RBD, WB) LS-C829813

Produktübersicht

• Artikelname: Recombinant Monoclonal Human anti-Coronavirus SARS-CoV-2 Spike Glycoprotein Antibody (ECD/RBD, WB) LS-C829813
• Artikelnummer: LS-C829813-100
• Hersteller Artikelnummer: LS-C829813-100
• Alternativnummer: LS-C829813-100
• Hersteller: LifeSpan Biosciences
• Wirt: Human
• Kategorie: Antikörper
• Applikation: ELISA, NeA, WB
• Spezies Reaktivität: Virus
• Immunogen: Synthetic peptide corresponding to SARS-CoV-2 Spike Glycoprotein ECD/RBD
• Konjugation: Unconjugated
• Alternative Synonym: sars-cov-2

Produktbeschreibung

SARS-CoV-2 Spike Glycoprotein antibody LS-C829813 is an unconjugated human recombinant monoclonal antibody to coronavirus sars-cov-2 Spike Glycoprotein (ECD/RBD). Validated for ELISA, Neut and WB.

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1 mg/ml
• Puffer: PBS, pH 7.2, 0.02% Sodium Azide, 10% glycerin
• Reinheit: Affinity-chromatography using epitope-specific immunogen to greater than 95% (by SDS-PAGE).
• Formulierung: PBS, pH 7.2, 0.02% Sodium Azide, 10% glycerin

Anwendungsbeschreibung

• Application Verdünnung: ELISA, Neut, WB (1:500 - 1:1000)
• Anwendungsbeschreibung: ELISA Dilution: ECD - 1:320000, RBD - 1:80000